- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04371237
Accelerating Post-exercise Muscle Glycogen Resynthesis in Humans: Impact of Combined Nutrient Intake and Intermittent Pneumatic Compression or Heat Therapy
March 8, 2021 updated by: PepsiCo Global R&D
To determine if modalities designed to improve blood flow combined with post-exercise nutrient intake will improve replenishment of muscle glycogen better than nutrient intake alone.
A secondary objective is to compare the effectiveness of heat therapy and intermittent pneumatic compression on glycogen replenishment.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue University, Department of Health & Kinesiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects will be male and female participants in good health
- 18-35 years of age
- Currently performing cardiovascular or intermittent exercise at a moderate to high intensity at least 5 days per week for 60 minutes or longer per day.
- Understanding of the procedures to be undertaken as part of the study
- Willingness to participate in exercise testing and follow instructions provided by the experimenter
- Informed, voluntary, written consent to participate in the study
Exclusion Criteria:
- History of deep vein thrombosis
- Obesity (BMI > 30 kg/m2)
- Hypertension (resting SBP > 140/90 mmHg)
- Smoking
- Pregnant, planning to become pregnant, or lactating
- Supplements containing antioxidants including vitamin C and E and N-acetyl cysteine
- Any medication
- Lactose intolerance
- Participation in another study within the previous 30 days or in a PepsiCo funded study within the past 6 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intermittent pneumatic compression
IPC sleeve device on leg
|
From foot to hip/groin on both legs with only 1 leg connected to pneumatic pump for 1 hour
Other Names:
Prolonged intermittent high intensity running (LIST protocol)
Post-exercise, all participants will receive a beverage containing 1.0 g/kg carbohydrate and 0.3 g/kg protein from the mixture of Gatorade Recover Protein Shake and Gatorade Thirst Quencher
Vastus lateralis muscle in the lower thigh will be obtained by the percutaneous needle technique
|
|
Experimental: Heat therapy
Custom water-circulating garment on leg
|
Prolonged intermittent high intensity running (LIST protocol)
Post-exercise, all participants will receive a beverage containing 1.0 g/kg carbohydrate and 0.3 g/kg protein from the mixture of Gatorade Recover Protein Shake and Gatorade Thirst Quencher
Vastus lateralis muscle in the lower thigh will be obtained by the percutaneous needle technique
Custom leg garment with one leg heated by circulating hot water approx 40 degrees C, the other leg approx 32 degrees C (thermoneutral) for 1 hour
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of glycogen resynthesis
Time Frame: Change from baseline to 1.5 hrs and 3.5 hrs post exercise bout. Biopsy 1 post-exercise pre nutrient intake 1 and compression (IPC) or heat, biopsy 2 post compression or heat, pre-nutrition intake 2, biopsy 3 at 210 min. Higher rate is better.
|
Leg skeletal muscle glycogen level assessment using assay kit
|
Change from baseline to 1.5 hrs and 3.5 hrs post exercise bout. Biopsy 1 post-exercise pre nutrient intake 1 and compression (IPC) or heat, biopsy 2 post compression or heat, pre-nutrition intake 2, biopsy 3 at 210 min. Higher rate is better.
|
|
Muscle functional recovery: Skeletal muscle function
Time Frame: Change from pre-exercise to post-exercise and prior to biopsies and treatments, and 24 hours post exercise. Less fatigue is better.
|
Work fatigue (%) of the knee extensors measured using an isokinetic dynamometer
|
Change from pre-exercise to post-exercise and prior to biopsies and treatments, and 24 hours post exercise. Less fatigue is better.
|
|
Muscle functional recovery: Perceived muscle soreness
Time Frame: Change from pre-exercise to post-exercise and prior to biopsies and treatments, and 24 hours post exercise. Less soreness is better.
|
Knee extensor muscle soreness on a visual analog scale (VAS) of 100 mm after stepping on and off a 40 cm (female) or 45 cm (male) box three times
|
Change from pre-exercise to post-exercise and prior to biopsies and treatments, and 24 hours post exercise. Less soreness is better.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mRNA expression of genes involved in regulation of glucose and glycogen metabolism and muscle functional recovery
Time Frame: Change from baseline to 1.5 hours and 3.5 hours post exercise bout. Biopsy 1 post-exercise pre- nutrient intake 1 and compression (IPC) or heat, biopsy 2 post compression or heat and pre- nutrition intake 2, biopsy 3 at 210 min. Higher expression better.
|
Leg skeletal muscle fiber analysis determined using RT-PCR (Real-time polymerase chain reaction)
|
Change from baseline to 1.5 hours and 3.5 hours post exercise bout. Biopsy 1 post-exercise pre- nutrient intake 1 and compression (IPC) or heat, biopsy 2 post compression or heat and pre- nutrition intake 2, biopsy 3 at 210 min. Higher expression better.
|
|
Serum insulin
Time Frame: Change from post exercise at same time as biopsy 1 (Time 0), biopsy 2 (1.5 hrs) and biopsy 3 (3.5 hrs)
|
Blood test using ELISA kit
|
Change from post exercise at same time as biopsy 1 (Time 0), biopsy 2 (1.5 hrs) and biopsy 3 (3.5 hrs)
|
|
Serum Glucose
Time Frame: Change from post exercise at same time as biopsy 1 (Time 0), biopsy 2 (1.5 hrs) and biopsy 3 (3.5 hrs
|
Blood test using ELISA kit
|
Change from post exercise at same time as biopsy 1 (Time 0), biopsy 2 (1.5 hrs) and biopsy 3 (3.5 hrs
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bruno Roseguini, PhD, Purdue University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 19, 2018
Primary Completion (Actual)
December 21, 2019
Study Completion (Actual)
December 21, 2019
Study Registration Dates
First Submitted
April 29, 2020
First Submitted That Met QC Criteria
April 29, 2020
First Posted (Actual)
May 1, 2020
Study Record Updates
Last Update Posted (Actual)
March 10, 2021
Last Update Submitted That Met QC Criteria
March 8, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEP-1723
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Soreness
-
Gazi UniversityCompletedDelayed Onset Muscle Soreness (DOMS)Turkey (Türkiye)
-
Applied Science & Performance InstituteNot yet recruitingMuscle Damage | Physical Performance | Muscle Recovery | Perceived Recovery | Strength Recovery | Perceived Muscle SorenessUnited States
-
Ebru Aloğlu ÇiftçiThe Scientific and Technological Research Council of TurkeyCompletedHealthy | Delayed Onset Muscle Soreness (DOMS)Turkey (Türkiye)
-
University of MinnesotaRecruitingExercise Induced Muscle Damage | Delayed Onset Muscle Soreness (DOMS)United States
-
University of Sistan and BaluchestanCompletedAthletic Injuries | Muscle Recovery | Exercise-induced Muscle Damage | Delayed-Onset Muscle Soreness (DOMS)Iran
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedDelayed-onset Muscle SorenessTaiwan
-
NewChapter, Inc.Procter and GambleCompletedDelayed Onset Muscle SorenessUnited States
-
Lotus Clinical Research, LLCNovartis PharmaceuticalsCompletedPain | Delayed Onset Muscle SorenessUnited States
-
Prof. Dr. med. Frank Christoph MoorenUniversity of Giessen; Biologische Heilmittel Heel GmbHCompletedExercise-induced Muscle SorenessGermany
-
Canopy Growth CorporationCompletedDelayed Onset Muscle Soreness (DOMS)United States
Clinical Trials on Compression sleeve
-
Nova Scotia Health AuthorityBauerfeindNot yet recruitingAnkle Fracture | Ankle ArthrodesisCanada
-
Massachusetts General HospitalNational Cancer Institute (NCI)TerminatedBreast Cancer | LymphedemaUnited States
-
Instituto Nacional de Cancer, BrazilCompletedBreast Neoplasms | Lymphedema of Upper Arm | Breast Cancer Related Lymphedema | Lymphedema, SecondaryBrazil
-
New York Institute of TechnologyCompleted
-
University of AlbertaAlberta Health services; Canadian Breast Cancer FoundationCompletedBreast Neoplasms | LymphedemaCanada
-
ThuasneInternational Clinical Trials AssociationCompletedLymphedema of Upper ArmFrance, Turkey
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedBreast Cancer | LymphedemaCanada
-
AHS Cancer Control AlbertaCompleted
-
ImpediMed LimitedVanderbilt University; Macquarie University, AustraliaCompletedLymphedemaUnited States, Australia
-
Institute of Technology, SligoSligo General HospitalSuspendedLymphedema of Upper ArmIreland